Cutaneous sıde‐effects of the potential <scp>COVID‐19</scp> drugs
Ümit Türsen, Belma Türsen, Torello Lotti
Abstract
COVID-19 disease is a highly contagious and particularly popular problem in all countries. A variety of repurposed drugs and investigational drugs such as remdesivir, chloroquine, hydroxychloroquine, ritonavir, lopinavir, interferon-beta, and other potential drugs have been studied for COVID19 treatment. We reviewed the potential dermatological side-effects of these drugs.
Topics & Concepts
HydroxychloroquineMedicineLopinavirCoronavirus disease 2019 (COVID-19)RitonavirChloroquineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakLopinavir/ritonavirPharmacologyVirologyDermatologyDiseaseImmunologyVirusInfectious disease (medical specialty)Internal medicineViral loadMalariaOutbreakAntiretroviral therapyDermatological and COVID-19 studiesDrug-Induced Adverse ReactionsCOVID-19 Clinical Research Studies